Eli Lilly cuts Zepbound price to widen access for obesity drug
Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as demand for
December 01, 2025
Pope cancels Holy See fundraising commission announced under questionable circumstances
Football players and officials arrested as part of probe into Turkey's betting scandal
Chaos erupts at Indian airports as country's largest airline cancels flights
German lawmakers approve plan to attract more military recruits that stops short of conscription
World shares mostly advance after Wall Street inches closer to its all-time high
Cauldron for Milan Cortina Winter Olympics lit at Italy's presidential palace with 2 months to go